Frontiers in Immunology | Vaccines and Molecular Therapeutics

Brief Research Report

Published on 09 Sep 2024

Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E

in Vaccines and Molecular Therapeutics

Yang Liu
Xiaoyu Liu
Weiwei Chen
Yunzhou Yu
Jianghui Meng
Jiafu Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469919

1,159 views

Mini Review

Published on 05 Sep 2024

Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies

in Vaccines and Molecular Therapeutics

Maya Weitzen
Mohammad Shahbazy
Saketh Kapoor
Etienne Caron

Frontiers in Immunology

doi 10.3389/fimmu.2024.1442783

3,133 views

Original Research

Published on 04 Sep 2024

The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment

in Vaccines and Molecular Therapeutics

Edina Komlodi-Pasztor
Marta Escarra-Senmarti
Danielle A. Bazer
Aastha Bhatnagar
Carlos A. Perez Heydrich
Marcus Messmer
Richard F. Ambinder
Douglas E. Gladstone
Laura Clayton
Amy Goodrich

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433442

2,968 views

Original Research

Published on 03 Sep 2024

Evaluating TRAIL and IP-10 alterations in vaccinated pregnant women after COVID-19 diagnosis and their correlation with neutralizing antibodies

in Vaccines and Molecular Therapeutics

Wei-Chun Chen
Shu-Yu Hu
Chao-Min Cheng
Ching-Fen Shen
Hui-Yu Chuang
Chin-Ru Ker
Der-Ji Sun
Ching-Ju Shen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415561

960 views

Original Research

Published on 03 Sep 2024

Safety assessment of anti-B cell maturation antigen chimeric antigen receptor T cell therapy: a real-world study based on the FDA adverse event reporting system database

in Vaccines and Molecular Therapeutics

Wei Liu
Shuzhi Lin
Xiaoying Zhu
Lin Yin
Qian Liu
Shuang Lei
Bianling Feng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433075

1,921 views
1 citation

Systematic Review

Published on 02 Sep 2024

The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis

in Vaccines and Molecular Therapeutics

Akram Al-Ibraheem
Ahmed Saad Abdlkadir
Dhuha Ali Al-Adhami
Mike Sathekge
Henry Hee-Seung Bom
Mohammad Ma’koseh
Asem Mansour
Hikmat Abdel-Razeq
Kamal Al-Rabi
Enrique Estrada-Lobato

Frontiers in Immunology

doi 10.3389/fimmu.2024.1424269

1,745 views

Clinical Trial

Published on 02 Sep 2024

Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5–11 years: a phase 2/3, randomized, active-controlled study

in Vaccines and Molecular Therapeutics

Rino Suzuki
Miharu Suda
Katsuyasu Ishida
Kei Furihata
Aisaku Ota
Kaori Takahashi
Sachiko Sakakibara
Tetsuo Nakayama
Fumihiko Takeshita

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445459

1,675 views
1 citation

Original Research

Published on 30 Aug 2024

Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters

in Vaccines and Molecular Therapeutics

Peter Zhou
Jacqueline Watt
Juntao Mai
Huibi Cao
Zhijie Li
Ziyan Chen
Rongqi Duan
Ying Quan
Anne-Claude Gingras
James M. Rini

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430928

1,480 views

Original Research

Published on 29 Aug 2024

The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming

in Vaccines and Molecular Therapeutics

Mohamed M. Shamseldin
Kaitlin A. Read
Jesse M. Hall
Jasmine A. Tuazon
Jessica M. Brown
Myra Guo
Yash A. Gupta
Rajendar Deora
Kenneth J. Oestreich
Purnima Dubey

Frontiers in Immunology

doi 10.3389/fimmu.2024.1439418

1,912 views

Original Research

Published on 29 Aug 2024

MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses

in Vaccines and Molecular Therapeutics

Patricia Pérez
David Astorgano
Guillermo Albericio
Sara Flores
Cristina Sánchez-Corzo
María A. Noriega
Pedro J. Sánchez-Cordón
Nuria Labiod
Rafael Delgado
José M. Casasnovas

Frontiers in Immunology

doi 10.3389/fimmu.2024.1420304

1,487 views

Original Research

Published on 29 Aug 2024

Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination

in Vaccines and Molecular Therapeutics

Lukas Page
Kevin Dennehy
Katharina Mueller
Philipp Girl
Eva Loell
Hellen Buijze
Johanna-Maria Classen
Helmut Messmann
Christoph Roemmele
Reinhard Hoffmann

Frontiers in Immunology

doi 10.3389/fimmu.2024.1423766

1,268 views

Mini Review

Published on 27 Aug 2024

The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines

in Vaccines and Molecular Therapeutics

Naina McCann
Margarete Paganotti Vicentine
Young Chan Kim
Andrew J. Pollard

Frontiers in Immunology

doi 10.3389/fimmu.2024.1457785

1,034 views

Original Research

Published on 27 Aug 2024

mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy

in Vaccines and Molecular Therapeutics

Anastasia Gangaev
Yannick van Sleen
Nicole Brandhorst
Kelly Hoefakker
Bimal Prajapati
Amrita Singh
Annemarie Boerma
Marieke van der Heiden
Sjoukje F. Oosting
Astrid A. M. van der Veldt

Frontiers in Immunology

doi 10.3389/fimmu.2024.1447555

1,643 views

Editorial

Published on 23 Aug 2024

Editorial: RNA vaccines for prevalent and newly emerging diseases

in Vaccines and Molecular Therapeutics

César López-Camacho
Mohamad Gabriel Alameh
Dan Peer
Pieter Culis

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474260

993 views
1 citation

Original Research

Published on 23 Aug 2024

Evaluation of inflammatory biomarkers and their association with anti-SARS-CoV-2 antibody titers in healthcare workers vaccinated with BNT162B2

in Vaccines and Molecular Therapeutics

Ester Leno-Duran
Esther Serrano-Conde
Ana Salas-Rodríguez
Inmaculada Salcedo-Bellido
Rocío Barrios-Rodríguez
Ana Fuentes
Laura Viñuela
Federico García
Pilar Requena

Frontiers in Immunology

doi 10.3389/fimmu.2024.1447317

1,054 views

Original Research

Published on 23 Aug 2024

Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics

in Vaccines and Molecular Therapeutics

Man Cui
Xiaohui Ji
Fengtao Guan
Guimin Su
Lin Du

Frontiers in Immunology

doi 10.3389/fimmu.2024.1432968

2,214 views

Navigation group

Articles

Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E

Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies

The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment

Evaluating TRAIL and IP-10 alterations in vaccinated pregnant women after COVID-19 diagnosis and their correlation with neutralizing antibodies

Safety assessment of anti-B cell maturation antigen chimeric antigen receptor T cell therapy: a real-world study based on the FDA adverse event reporting system database

The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis

Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5–11 years: a phase 2/3, randomized, active-controlled study

Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters

The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming

MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses

Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination

The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines

mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy

Editorial: RNA vaccines for prevalent and newly emerging diseases

Evaluation of inflammatory biomarkers and their association with anti-SARS-CoV-2 antibody titers in healthcare workers vaccinated with BNT162B2

Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics